All Articles

Integrated multi-omics profiling of immune microenvironment and drug resistance signatures for precision prognosis in prostate cancer

Overcoming drug resistance in castrate-resistant prostate cancer: current mechanisms and emerging therapeutic approaches

Ritonavir reverses resistance to docetaxel and cabazitaxel in prostate cancer cells with acquired resistance to docetaxel

A review of strategies to overcome immune resistance in the treatment of advanced prostate cancer

The multifaceted role of extracellular vesicles in prostate cancer-a review

Interaction of pregnane X receptor with hypoxia-inducible factor-1 regulates chemoresistance of prostate cancer cells

New insights for drug resistance in metastatic castration-resistant prostate cancer

Drug resistance in metastatic castration-resistant prostate cancer: an update on the status quo

Role of extracellular vesicles secretion in paclitaxel resistance of prostate cancer cells

Role of prostate cancer stem-like cells in the development of antiandrogen resistance

ONECUT2 as a key mediator of androgen receptor-independent cell growth and neuroendocrine differentiation in castration-resistant prostate cancer

Tousled-like kinase 1: a novel factor with multifaceted role in mCRPC progression and development of therapy resistance

HDAC inhibitors with potential to overcome drug resistance in castration-resistant prostate cancer

Metabolic reprogramming as an emerging mechanism of resistance to endocrine therapies in prostate cancer

Oxidative stress and redox signaling in CRPC progression: therapeutic potential of clinically-tested Nrf2-activators

Intracrine androgen biosynthesis and drug resistance

MicroRNAs in treatment-induced neuroendocrine differentiation in prostate cancer

Resistance to second generation antiandrogens in prostate cancer: pathways and mechanisms